Neuroprotective Effects of Cryptotanshinone in a Direct Reprogramming Model of Parkinson’s Disease

Neuroprotective Effects of Cryptotanshinone in a Direct Reprogramming Model of Parkinson’s Disease

Parkinson’s disease (PD) is a well-known age-related neurodegenerative disease. Considering the vital importance of disease modeling based on reprogramming technology, we adopted direct reprogramming to human-induced neuronal progenitor cells (hiNPCs) for in vitro assessment of potential therapeutic...

Full description

Bibliographic Details
Main Authors:	Joo-Eun Lee, Hyuna Sim, Hee Min Yoo, Minhyung Lee, Aruem Baek, Young-Joo Jeon, Kang-Sik Seo, Mi-Young Son, Joo Seog Yoon, Janghwan Kim
Format:	Article
Language:	English
Published:	MDPI AG 2020-08-01
Series:	Molecules
Subjects:	Parkinson’s disease cryptotanshinone disease modeling mitochondrial dysfunction antioxidant
Online Access:	https://www.mdpi.com/1420-3049/25/16/3602

Similar Items

The Influence of Selected Factors on the Aqueous Cryptotanshinone Solubility
by: Justyna Kobryń, et al.
Published: (2021-06-01)

Stimulation of Eryptosis by Cryptotanshinone
by: Rosi Bissinger, et al.
Published: (2014-07-01)

Cryptotanshinone attenuates LPS-induced acute lung injury by regulating metabolic reprogramming of macrophage
by: Zesen Ye, et al.
Published: (2023-01-01)

Cryptotanshinone ameliorates cladribine-induced cognitive impairment in rats
by: Khadga Raj Aran, et al.
Published: (2023-01-01)

In Vitro Effects of Cryptotanshinone on Early Atherogenic Events Induced by Oxidized Low Density Lipoprotein and Tumour Necrosis Factor-α
by: Ang, Kok Pian
Published: (2010)

Novel perspectives on the therapeutic role of cryptotanshinone in the management of stem cell behaviors for high-incidence diseases
by: Xiaomeng Guo, et al.
Published: (2022-08-01)

Hyperthermia Using Antibody-Conjugated Magnetic Nanoparticles and Its Enhanced Effect with Cryptotanshinone
by: Satoshi Ota, et al.
Published: (2014-04-01)

Preparation and optimization of surface stabilized cryptotanshinone nanocrystals with enhanced bioavailability
by: Wenzheng Zhao, et al.
Published: (2023-02-01)

Cryptotanshinone ameliorates CUS-induced depressive-like behaviors in mice
by: Wang Kaixin, et al.
Published: (2021-11-01)

Cryptotanshinone-Induced Permeabilization of Model Phospholipid Membranes: A Biophysical Study
by: Julia Ortiz, et al.
Published: (2024-05-01)

Prospective pharmacological potential of cryptotanshinone in cancer therapy
by: Ashif Ahamed, et al.
Published: (2023-12-01)

Design, Synthesis, and Evaluation of Novel Cryptotanshinone Derivatives for Activity against Triple-Negative Breast Cancer
by: Siyu Liu, et al.
Published: (2024-06-01)

Pharmacological Mechanisms of Cryptotanshinone: Recent Advances in Cardiovascular, Cancer, and Neurological Disease Applications
by: Zheng Z, et al.
Published: (2024-12-01)

An in-silico study examining the induction of apoptosis by Cryptotanshinone in metastatic melanoma cell lines
by: Radhika S. Saraf, et al.
Published: (2018-08-01)

Activation of dynamin-related protein 1 - dependent mitochondria fragmentation and suppression of osteosarcoma by cryptotanshinone
by: Jia-Hau Yen, et al.
Published: (2019-01-01)

Carrier-free cryptotanshinone-peptide conjugates self-assembled nanoparticles: An efficient and low-risk strategy for acne vulgaris
by: Quanfu Zeng, et al.
Published: (2024-08-01)

Potential binding of cryptotanshinone with hemoglobin and antimetastatic effects against breast cancer cells through alleviating the expression of MMP-2/-9
by: Yanling Ma, et al.
Published: (2023-10-01)

Tanshinone IIA and Cryptotanshinone Counteract Inflammation by Regulating Gene and miRNA Expression in Human SGBS Adipocytes
by: Sara Carpi, et al.
Published: (2023-06-01)

Preparation and characterisation of solid dispersions of tanshinone IIA, cryptotanshinone and total tanshinones
by: Xifeng Zhai, et al.
Published: (2017-01-01)

Cryptotanshinone against vascular dementia through inhibition of Aβ aggregation and inflammatory responses in cerebrovascular endothelial cells
by: Hongmei Ding, et al.
Published: (2022-12-01)

Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells
by: Wenxing Chen, et al.
Published: (2017-01-01)

Effect of Co-Solvents, Modified Starch and Physical Parameters on the Solubility and Release Rate of Cryptotanshinone from Alcohologels
by: Justyna Kobryń, et al.
Published: (2024-12-01)

Cryptotanshinone inhibits ovarian tumor growth and metastasis by degrading c-Myc and attenuating the FAK signaling pathway
by: Huijun Guo, et al.
Published: (2022-09-01)

Cryptotanshinone Ameliorates Doxorubicin-Induced Cardiotoxicity by Targeting Akt-GSK-3β-mPTP Pathway In Vitro
by: Xiaoping Wang, et al.
Published: (2021-03-01)

Mechanism of Cryptotanshinone Inhibiting Proliferation of Human Breast Cancer MCF7 Cells
by: YANG Shuhan, et al.
Published: (2023-10-01)

Anticancer potential of cryptotanshinone on breast cancer treatment; A narrative review
by: Davood Dalil, et al.
Published: (2022-09-01)

Cryptotanshinone Reverses Corticosteroid Insensitivity by Inhibition of Phosphoinositide-3-Kinase-δ in Chronic Obstructive Pulmonary Disease
by: Xie T, et al.
Published: (2023-05-01)

Cryptotanshinone inhibits PFK-mediated aerobic glycolysis by activating AMPK pathway leading to blockade of cutaneous melanoma
by: Qiong Chen, et al.
Published: (2024-03-01)

Pharmacokinetics and tissue distribution of bleomycin-induced idiopathic pulmonary fibrosis rats treated with cryptotanshinone
by: Xiangjun He, et al.
Published: (2023-03-01)

Cryptotanshinone Protects Cartilage against Developing Osteoarthritis through the miR-106a-5p/GLIS3 Axis
by: Quanbo Ji, et al.
Published: (2018-06-01)

Cryptotanshinone increases the sensitivity of liver cancer to sorafenib by inhibiting the STAT3/Snail/epithelial mesenchymal transition pathway
by: Li Zhiyu, et al.
Published: (2022-05-01)

Exploring the therapeutic potency of cryptotanshinone in cervical cancer: a multi-omics and network pharmacology approach
by: Zenghong Lu, et al.
Published: (2024-11-01)

A small molecule cryptotanshinone induces non-enzymatic NQO1-dependent necrosis in cancer cells through the JNK1/2/Iron/PARP/calcium pathway
by: Ying Hou, et al.
Published: (2025-02-01)

Metabolism of Tanshinone IIA, Cryptotanshinone and Tanshinone I from Radix Salvia Miltiorrhiza in Zebrafish
by: Bing Wang, et al.
Published: (2012-07-01)

Metabolic remodeling in tumor-associated macrophages contributing to antitumor activity of cryptotanshinone by regulating TRAF6-ASK1 axis
by: Jia-Hau Yen, et al.
Published: (2022-09-01)

Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis
by: Ying Liu, et al.
Published: (2020-05-01)

Study on the Intervention Mechanism of Cryptotanshinone on Human A2780 Ovarian Cancer Cell Line Using GC-MS-Based Cellular Metabolomics
by: Tong Wang, et al.
Published: (2023-06-01)

Quantitative Proteomic Analysis of Primitive Neural Stem Cells from LRRK2 G2019S-Associated Parkinson’s Disease Patient-Derived iPSCs
by: Hyuna Sim, et al.
Published: (2020-12-01)

Effect and mechanism of cryptotanshinone on early pulmonary fibrosis in LPS-induced acute respiratory distress syndrome in mice
by: ZHANG Renzi, et al.
Published: (2022-09-01)

Targeted Therapy of Acute Liver Injury via Cryptotanshinone-Loaded Biomimetic Nanoparticles Derived from Mesenchymal Stromal Cells Driven by Homing
by: Xin Zhang, et al.
Published: (2023-12-01)